• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Ziemer Ophthalmics' femtosecond laser receives FDA clearance

Article

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

The system's state-of-the-art laser technology generates shorter, smaller, lower-energy infrared laser pulses that dissect corneal tissue with unprecedented smoothness and precision, according to the company.

Shipment of the system, which designed for a wide range of applications in corneal surgery, is expected in June 2006.

For more information, visit Ziemer Ophthalmics at Booth 1010.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
William F. Wiley, MD, shares some key takeaways from his ASCRS presentation on binocularity and aperture optics.
© 2024 MJH Life Sciences

All rights reserved.